Breaking News

SCA Buys BSN Medical

December 19, 2016

Company has leading brands in wound care, compression therapy and orthopedic markets

SCA has entered into an agreement to acquire BSN Medical, a leading medical solutions company, from the private equity group EQT. BSN medical develops, manufactures, markets and sells products within wound care, compression therapy and orthopedics. The purchase price amounts to €2.74 billion on a debt- and cash-free basis. The completion of the transaction is subject to customary regulatory approvals. Closing is expected to take place during the second quarter 2017.

BSN medical is an innovative medical solutions company with well-known brands such as Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove which are long established brand leaders in their key markets. BSN medical has a strong go-to-market and supply chain with sales in more than 140 countries and production in 11 countries. BSN medical has approximately 6000 employees.

“The BSN medical acquisition is an excellent strategic fit for SCA supporting our vision to improve well-being through leading hygiene and health solutions, two closely interlinked areas. BSN medical has leading market positions in several attractive medical product categories and provides a new growth platform with future industry consolidation opportunities. Our incontinence business, with the global leading Tena brand, shares  similar positive market characteristics, customer and sales channels, which provide opportunities for accelerated growth through cross-selling,” says Magnus Groth, President and CEO, SCA.

BSN medical reported net sales werer €861 million in 2015 while its adjusted EBITDA was €201 million. The acquisition is expected to be accretive to SCA’s earnings per share from year one. BSN medical has high cash conversion and an asset light business model.

BSN medical’s global addressable market size 2015 is estimated to amount to EUR 11.6bn*****, with an estimated market growth (CAGR 2015-2020) of approximately 4%*****, mainly driven by an aging population, increased prevalence of chronic conditions and increased access to health care.

 “BSN medical provides an opportunity for SCA to expand our market presence through adding adjacent medical product categories with shared underlying market and customer characteristics of our incontinence business. This acquisition will significantly strengthen SCA’s customer offering, channel presence and market access. This will further strengthen and develop SCA’s global market leading position within incontinence products under the TENA brand. At the same time, the BSN medical business will benefit from SCA’s strong presence in healthcare and retail sales channels as well as SCA’s extensive knowledge in brand building and focus on digitalization,” says Groth.

Related Application:

Related Market:

Related Other: